Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones
Public ClinicalTrials.gov record NCT02503345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multi-center, Randomized, Double Blind, Placebo-controlled, Crossover Study to Evaluate Multiple Doses of ALLN-177 in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Study identification
- NCT ID
- NCT02503345
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Allena Pharmaceuticals
- Industry
- Enrollment
- 32 participants
Conditions and interventions
Conditions
Interventions
- ALLN-177 low dose Drug
- ALLN-177 mid dose Drug
- ALLN-177 high dose Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2015
- Primary completion
- Jul 31, 2016
- Completion
- Dec 31, 2016
- Last update posted
- Jan 10, 2018
2015 – 2017
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tower Urology | Los Angeles | California | 90048 | — |
| Atlantic Urological Associates | Daytona Beach | Florida | 32114 | — |
| Mayo Clinic - Nephrology And Hypertension | Jacksonville | Florida | 32224 | — |
| Northwestern Feinberg School Of Medicine - Urology Department | Chicago | Illinois | 60611 | — |
| IU Health Physicians Urology | Indianapolis | Indiana | 46202 | — |
| Anne Arundel Urology | Annapolis | Maryland | 21401 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Mayo Clinic | Rochester | Minnesota | 55902 | — |
| Brooklyn Urology Research Group | Brooklyn | New York | 11694 | — |
| North Shore Long Island Jewish Health System/The Arthur Miller Institute for Urology | Lake Success | New York | 11042 | — |
| New York University - Division Of Nephrology | New York | New York | 10016 | — |
| The Urology Group | Cincinnati | Ohio | 45212 | — |
| Cleveland Clinic-Urology | Cleveland | Ohio | 44195 | — |
| Omega Clinical Research | Warwick | Rhode Island | 02886 | — |
| UT Southwestern Medical Center - Urology | Dallas | Texas | 75390 | — |
| Urology of Virginia | Virginia Beach | Virginia | 23462 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02503345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 10, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02503345 live on ClinicalTrials.gov.